We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Neurology

Journal Scan / Research · September 24, 2019

Long-Term Antithrombotic Therapy and Risk of Intracranial Hemorrhage From Cerebral Cavernous Malformations

The Lancet Neurology


Additional Info

The Lancet Neurology
Long-Term Antithrombotic Therapy and Risk of Intracranial Haemorrhage From Cerebral Cavernous Malformations: A Population-Based Cohort Study, Systematic Review, and Meta-Analysis
Lancet Neurol 2019 Aug 06;[EPub Ahead of Print], SM Zuurbier, CR Hickman, CS Tolias, LA Rinkel, R Leyrer, KD Flemming, D Bervini, G Lanzino, RJ Wityk, HM Schneble, U Sure, R Al-Shahi Salman

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading